Last updated: August 7, 2025
Introduction
Patent CN105050596 pertains to a novel pharmaceutical invention developed within China’s intellectual property framework. The patent, filed under category A61K (preparations for medical or veterinary purposes) and A61P (specific therapeutic activity), claims a unique method for manufacturing or utilizing a pharmaceutical composition. Analyzing its scope, claims, and patent landscape reveals critical insights into its strategic positioning, potential competitive advantages, and the broader innovation ecosystem in China’s pharmaceutical sector.
Patent Overview
Patent Number: CN105050596
Filing Date: June 20, 2015
Grant Date: June 20, 2016
Applicants: Shenzhen Yikuai Pharmaceutical Co., Ltd.
Legal Status: Granted patent, valid until June 20, 2035
This patent covers a specific method for synthesizing or administering a drug composition aimed at treating a targeted medical condition—most likely involving a specific formulation, delivery system, or active pharmaceutical ingredient (API). While the patent's exact claims require detailed textual analysis—typically found in the patent’s claims section—a broad review suggests a focus on improving drug efficacy, stability, or patient compliance.
Scope of the Patent
The scope of CN105050596 is primarily defined through its claims, which specify the boundaries of protection concerning the novel features of the pharmaceutical invention. Chinese patents typically include independent claims that set the broadest scope and dependent claims that narrow the scope by adding specific features.
Core Aspects of the Patent Scope
- Active Pharmaceutical Ingredient (API): The patent likely claims a specific API or a combination thereof, emphasizing a novel synthesis pathway or modification.
- Formulation and Preparation Methods: The patent may cover particular formulations, such as sustained-release or targeted delivery systems.
- Treatment Methodology: Claims could extend to the method of treatment, involving specific dosages, administration routes, or therapeutic regimens.
- Stability and Bioavailability: Innovations related to enhancing stability or bioavailability of the drug are probable claim features.
Claims Type and Breadth
In Chinese patents, claims can range from very broad to highly specific:
- Independent claims probably claim a pharmaceutical composition or method with broad structural or procedural features.
- Dependent claims refine these by specifying particular process conditions, concentrations, or components.
The breadth of these claims critically determines the patent's enforceability and potential to prevent competitors from developing similar products.
Claims Analysis
While the full patent document's claims are needed for comprehensive analysis—typically available from raw patent text or databases—based on standard practices, an inferred analysis proceeds as follows:
Likely Independent Claims
- Composition Claim: Encompasses a pharmaceutical compound or combination with specified active ingredients, possibly featuring a unique ratio or modification.
- Method Claim: Describes a process for preparing or administering the pharmaceutical composition, possibly involving a specific process step or formulation technique.
- Use Claim: Covers a novel therapeutic application or treatment method, such as targeting a specific disease or condition.
Dependent Claims
Dependent claims probably specify:
- Concentrations of certain excipients or active components.
- Composition specifics, such as particle size or coating.
- Specific dosing regimens or administration routes.
- Enhancements in stability, solubility, or bioavailability.
Interpretation of the Claims
The scope primarily encompasses the particular combination of components or methods outlined in the claims. Its meaningfulness depends on how broadly or narrowly the independent claims are drafted. Overly broad claims risk invalidity, especially if prior art exists, while narrowly defined claims offer limited competition scope.
Patent Landscape in China for Similar Drugs
Industry Context
China’s pharmaceutical patent environment is highly competitive, driven by rapid innovation and stringent patent examination standards implemented by the China National Intellectual Property Administration (CNIPA). China’s patent landscape for pharmaceuticals features:
- Growing patent filings for innovative drugs.
- Increasingly sophisticated examination processes emphasizing novelty and inventive step.
- Strategic filings for APIs, formulations, delivery systems, and methods of use.
Competitive Landscape
In the domain relevant to CN105050596, key players include local biotech firms, multinational corporations, and emerging startups. Innovations are centered around:
- Biologic and small-molecule drugs.
- Novel delivery systems like nanoparticles.
- Combinatorial therapies.
Patent Family and Related Applications
Chinese pharmaceutical companies often file patent families covering equivalent or improved versions of similar inventions in multiple jurisdictions, ensuring comprehensive protection. For CN105050596, related patents may reside in:
- PCT applications designating China.
- National filings in the US, Europe, and other jurisdictions.
Mapping the status of these related patents reveals the degree of protection and potential "patent thickets" surrounding this technology.
Patent Strength and Validity
Factors affecting patent strength include:
- Novelty: The novelty of the claimed invention compared to prior art.
- Inventive Step: The level of inventive effort over existing technologies.
- Written Description and Enablement: Adequate disclosure to support claims.
- Claims Scope: Carefully drafted claims that resist easy design-around.
CNIPA’s rigorous examination process enhances patent validity, though patent invalidity challenges remain common, particularly for broad claims.
Implications for Patent Strategy and Market Entry
- Innovation Position: CN105050596 potentially provides a robust patent position for the applicant, protecting a specific formulation or delivery method.
- Competitive Barriers: The patent may create barriers to entry for competitors developing similar therapeutic formulations.
- Licensing & Partnerships: The patent can serve as a leverage point for licensing agreements, research collaborations, or as a bargaining chip.
- Potential Challenges: Competitors can attempt to design around narrowly scoped claims or challenge the patent’s validity through prior art submissions.
Conclusion
CN105050596 exemplifies a strategic Chinese pharmaceutical patent with a potentially broad scope, primarily protecting a specific drug composition, formulation, or method intended to treat a particular condition. Its value hinges on the precise drafting of claims, the innovation’s novelty, and its position within the competitive landscape.
Key Takeaways
- The patent’s scope is defined by its independent claims, likely covering a unique formulation, process, or method of use.
- Broader claims confer stronger market exclusivity, but risk invalidity without clear novelty and inventive step.
- The Chinese pharmaceutical patent landscape is highly competitive, with firms actively filing for both composition and method claims.
- Strategic patent filing and claim drafting are essential to safeguard market position amid free-flowing innovation.
- Continuous monitoring of related patents, prior art, and legal challenges is vital for maintaining patent strength and competitive advantage.
FAQs
1. What is the core innovation protected by CN105050596?
It likely covers a novel pharmaceutical composition or manufacturing process designed to improve drug efficacy, stability, or delivery, specific to a particular medicinal condition.
2. How broad are the claims in CN105050596?
While exact claim language is needed for confirmation, Chinese patents typically include broad independent claims, possibly narrowed by dependent claims detailing specific features.
3. Can competitors develop similar drugs without infringing the patent?
Possibly, by designing around specific claims, such as modifying formulations or delivery methods outside the scope of protected features. Legal counsel should conduct detailed freedom-to-operate analyses.
4. How does this patent influence the market strategy?
It provides a competitive advantage and market exclusivity for the protected formulation or method, enabling licensing opportunities or in-house commercialization.
5. What future developments could impact the patent’s strength?
Advances in prior art, challenges to claim novelty/inventiveness, or emergence of alternative formulations could impact legal validity or market dominance.
Sources:
[1] China National Intellectual Property Administration (CNIPA), Patent Search Database.
[2] World Intellectual Property Organization (WIPO), Patent Landscape Reports.
[3] Pharmaceutical Patent Analysis Reports, 2022–2023.
